A palliative care attending physician at a tertiary medical center is reviewing several patient charts to formulate targeted recommendations for symptom control and care transitions. Match each of the following clinical scenarios with the most appropriate next step in palliative or end-of-life management.
- A patient with advanced bone metastases on high-dose morphine develops severe myoclonus, hyperalgesia, and worsening renal function.Rotate the current analgesic regimen to fentanyl or methadone.
- A patient with end-stage chronic obstructive pulmonary disease and frequent exacerbations who wishes to forgo future hospitalizations and focus solely on comfort at home.Enroll the patient in a comprehensive home hospice care program.
- A patient with terminal amyotrophic lateral sclerosis experiencing severe, refractory agitated delirium and dyspnea unresponsive to aggressive opioid and haloperidol titration.Initiate palliative sedation using a continuous infusion of midazolam.
- An actively dying patient in an inpatient hospice setting who develops loud, gurgling respiratory secretions that are distressing to the family.Administer an anticholinergic agent such as sublingual atropine or subcutaneous glycopyrrolate.
Answer
The correct matches align specific palliative challenges with their targeted interventions: opioid neurotoxicity requires opioid rotation; the desire for exclusive home comfort care requires home hospice enrollment; refractory terminal suffering requires palliative sedation; and terminal respiratory secretions require anticholinergics.
Each clinical scenario presents a classic presentation of a palliative care challenge. Recognizing opioid neurotoxicity prompts opioid rotation; respecting a patient's wish for exclusive home comfort care prompts hospice enrollment; encountering refractory terminal symptoms prompts palliative sedation; and observing terminal respiratory secretions prompts the use of drying anticholinergic agents.
Step-by-Step Solution
Key Concept
Appropriate evidence-based management of end-of-life symptoms and care transitions.